Clinical and Pathological Relevance of Drug-induced Vitiligo in Patients Treated for Metastatic Melanoma with Anti-PD1 or BRAF/MEK Inhibitors

Current therapies for metastatic melanoma (anti-PD1 and BRAF/MEK inhibitors) can cause drug-induced vitiligo. The aim of this study is to dermatologically define and histologically characterize this new type of vitiligo, and assess the clinical course of the disease. Fourteen patients with metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: RAMONDETTA, Alice, RIBERO, Simone, CONTI, Luca, FAVA, Paolo, MARRA, Elene, BROGANELLI, Paolo, CALIENDO, Virginia, PICCIOTTO, Franco, GUIDA, Michele, FIERRO, Maria Teresa, QUAGLINO, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2020
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128901/
https://www.ncbi.nlm.nih.gov/pubmed/31532537
http://dx.doi.org/10.2340/00015555-3319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128901/
https://www.ncbi.nlm.nih.gov/pubmed/31532537
http://dx.doi.org/10.2340/00015555-3319

Ejemplares similares